Neurizon's ALS Drug Candidate Receives Orphan Medicinal Product Designation in Europe; Shares Down 3%

MT NewswiresDec 17 21:41 ET

Neurizon Reports Positive Results From Preclinical Study of Amyotrophic Lateral Sclerosis Treatment Candidate; Shares Fall 4%

MT NewswiresNov 17 23:34 ET

Neurizon's Fast-track Application for Flagship Drug in Europe Received 'Positively'

The Market HeraldNov 10 18:54 ET

PharmAust Changes Name to Neurizon Therapeutics

MT NewswiresOct 15 00:42 ET